In SELECT, semaglutide reduced major adverse cardiovascular events (HR 0.80
Why people choose it: FDA-approved with extensive safety data Reduces hunger and cravings significantly Helps control blood sugar and insulin levels Clinically proven to support 15 percent average body weight loss Once-weekly injection for convenience Common side effects: Nausea (especially during dose titration), diarrhea, constipation, vomiting, and abdominal pain
Retatrutide is an investigational medication that works differently
It can causes nausea, stomach cramps, decreased appetite, flushing, tiredness, yawning, darkened skin, spontaneous erections of the penis, and other side effects
Briefly, the extraction uses non-buffered alcohol solution mixture, heated to induce protein unfolding and releasing cofactors while preserving redox-sensitive metabolites